His research focuses on the discovery of compounds from microbial sources for development against a range of potential therapeutic targets in oncology and infectious diseases. He also serves as Director of the Institute for Natural Products Applications and Research Technologies, which is a collaborative initiative aimed at the development of new drug leads.